ISSN: 2582-1962 Cape Comorin An International Multidisciplinary Double-Blind Peer-reviewed Research Journal Special Issue, Volume II Issue IV May 2020 18 capecomorinjournal.org.in The Epidemiological Features and Details of the Outbreak in Indian Cities of Novel Corona Virus Diseases 2019 (COVID-19) India, 2020 Payel Saha, Library Assistant, School of Nursing, KIIT Deemed to be University, Bhubaneswar, Odisha, India Kalyani Rath, Associate Professor, School of Nursing, KIIT Deemed to be University, Bhubaneswar, Odisha, India Niyati Das, Vice Principle,School of Nursing, KIIT Deemed to be University, Bhubaneswar, Odisha, India Abstract: Background: An outbreak of 2019 novel corona virus diseases (COVID-19) has spread rapidly through India. Here we share findings from a descriptive, exploratory review of all cases reported in India as of 25 April 2020. Methods: All COVID-19 reported cases were collected from India's Infectious Disease Information System through April 25th, 2020.Analysis included: 1) description of patient characteristics; 2) analysis of age ranges and sex ratios; 3) measurement of case fatality and mortality rates; 4)Covid-19 laboratory in India; 5) development of an epidemiological curve; Results: A total of 24532 reports of patients—18254 confirmed cases, 18254 active cases, 780 deaths, 5498 recovered; Most of the confirmed patients were aged from 30–79 years.1, 386 counties were affected in all 31 provinces. The onset of symptoms outbreak curve peaked around February, and then started to decline until April 25th. Conclusions: The COVID-19 epidemic was spreading very fast. With many people coming back from a long holiday, India needs to brace for the possible rebound of the epidemic. Introduction: A cluster of unexplained pneumonia cases in India created alarm among health officials in February. In February 2020, the fatal decease covid-19 spread in India. It was spread throughout several countries; the Govt issued a warning. It had been declared a pandemic by India and the WHO. The World Health Organization (WHO) has been notified there. Likely potential causes including influenza, avian influenza, adenovirus, severe corona virus acute respiratory syndrome (SARS-CoV), and corona virus respiratory syndrome (MERS-CoV) in the Middle East were excluded. The causative pathogen was identified as a novel corona virus, which culminated in the development of genomic characterization and the test process. Now named 2019-nCoV, the virus is separate, but closely related, from both SARS-CoV and MERS-CoV.Early cases revealed COVID-19 may be less serious than SARS and MERS. However, the onset of disease among fast-growing numbers of people and increasing evidence of human-to-human transmission suggests that 2019- nCoV is more contagious than both SARS-CoV and MERSCoV. Characterization of COVID-19's epidemiological features is essential to the creation and implementation of successful control strategies. The findings of a concise, exploratory review of all cases found through April 25, 2020 are published here. Method Study Design This research was a descriptive, exploratory review of all COVID-19 cases reported in India nationwide as of the end of April 25th, 2020.As such, it uses a cross-sectional sample design in certain respects and thus, we used the Guidelines (www.covid19ind.org) to assist in our detailed reporting of this observational analysis. Data Source By categorizing COVID-19 as a Class B notifiable disease, Indian law demanded that all cases be reported to the Infectious Disease Information System of India immediately. Local epidemiologists and public health workers performed the entry of each case into the system, which investigated and collected information about possible exposures. By categorizing COVID-19 as a Class B notifiable disease, India's law required that all cases be reported to the Infectious Disease Information System of India immediately. Local epidemiologists and public health workers who investigated and gathered information about possible exposures performed entering each case into the system. All case records contain national identification numbers, and therefore, all cases have records in the system and no records are duplicated. All data contained in all COVID-19 case records in the Infectious Disease Information System through the end of April 25th, 2020 were extracted from the system as a single dataset and were then stripped of all personal identifying information.